Arcutis Biotherapeutics, Inc. (ARQT)
24.16
+0.24
(+1.00%)
USD |
NASDAQ |
Oct 07, 16:00
24.01
-0.15
(-0.62%)
After-Hours: 17:49
Arcutis Biotherapeutics EPS Diluted (Quarterly) : 0.1104 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.1104 |
| March 31, 2026 | -0.0873 |
| December 31, 2025 | 0.1282 |
| September 30, 2025 | 0.0558 |
| June 30, 2025 | -0.1251 |
| March 31, 2025 | -0.1988 |
| December 31, 2024 | -0.0864 |
| September 30, 2024 | -0.3342 |
| June 30, 2024 | -0.4238 |
| March 31, 2024 | -0.3186 |
| December 31, 2023 | -0.716 |
| September 30, 2023 | -0.7252 |
| June 30, 2023 | -1.156 |
| March 31, 2023 | -1.310 |
| December 31, 2022 | -1.181 |
| September 30, 2022 | -1.887 |
| Date | Value |
|---|---|
| June 30, 2022 | -1.311 |
| March 31, 2022 | -1.273 |
| December 31, 2021 | -1.421 |
| September 30, 2021 | -1.137 |
| June 30, 2021 | -0.8402 |
| March 31, 2021 | -0.7623 |
| December 31, 2020 | -0.7923 |
| September 30, 2020 | -1.012 |
| June 30, 2020 | -0.9421 |
| March 31, 2020 | -1.155 |
| December 31, 2019 | -0.33 |
| September 30, 2019 | -0.3996 |
| June 30, 2019 | -0.2176 |
| March 31, 2019 | -0.1748 |
| December 31, 2018 | -0.1546 |
| September 30, 2018 | -0.2118 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.1822 |
| Insmed, Inc. | -0.0609 |
| Emergent BioSolutions, Inc. | -3.492 |
| Exelixis, Inc. | 0.8166 |
| Puma Biotechnology, Inc. | 0.1557 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 15.01M |
| Revenue (Quarterly) | 129.86M |
| Total Expenses (Quarterly) | 114.85M |
| Enterprise Value | 2.879B |
| Gross Profit Margin (Quarterly) | 91.58% |
| Profit Margin (Quarterly) | 11.56% |
| Earnings Yield | 0.86% |
| Operating Earnings Yield | 1.06% |
| Normalized Earnings Yield | 0.8589 |